Company · BDTX (NASDAQ - All Markets)
Black Diamond Therapeutics, Inc.
Biological Products, (No Diagnostic Substances)
Key figures
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Institutional holders
- 96 at 30 Jun 2026 (104 the quarter before) · Who holds it
- SEC number
- 1701541
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 1 Oct 2026
Questions and answers
- Where is Black Diamond Therapeutics, Inc. listed?
- Black Diamond Therapeutics, Inc. trades as BDTX on NASDAQ - All Markets. Tamarly shows no share prices.
- How many institutions hold Black Diamond Therapeutics, Inc.?
- 96 institutional holders reported it on SEC Form 13F for the period ended 30 Jun 2026, against 104 the quarter before.
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.